Document is current
Any future updates will be listed below
-
Authors
Wada, Naoki https://orcid.org/0000-0002-9587-6798
Mizunaga, Mitsuhiro
Abe, Noriyuki
Miyauchi, Kotona
Kobayashi, Shin
Ohtani, Miyu
Tsunekawa, Ryoken
Nagabuchi, Masaya
Morishita, Shun
Ohyama, Teppei
Yamaguchi, Satoshi
Iuchi, Hiromichi
Noda, Tsuyoshi
Saga, Yuji
Motoya, Tadasu
Kawakami, Norihiro
Nishihara, Masayuki
Numata, Atsushi
Kakizaki, Hidehiro
- License Information
-
More Information
Article History
Received: 12 July 2023
Accepted: 16 January 2024
First Online: 2 March 2024
Declarations
:
: Naoki Wada received speaker honorarium from Astellas Pharma Inc. Hidehiro Kakizaki received speaker honorarium from Astella Pharma Inc., Kyorin and Kissei. The other authors declare that they have no conflicts of interest to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The ethics committee of Asahikawa Medical University approved the study protocol (approval number:18174).
: Informed consent was obtained from all individual participants included in the study before enrollment. This study was registered at as UMIN000034720.
